Viewing Study NCT01627132


Ignite Creation Date: 2025-12-24 @ 9:44 PM
Ignite Modification Date: 2025-12-25 @ 7:24 PM
Study NCT ID: NCT01627132
Status: UNKNOWN
Last Update Posted: 2012-06-25
First Post: 2012-02-14
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Discontinuation of Dasatinib in Patients With Chronic Myeloid Leukemia-CP Who Have Maintained Complete Molecular Remission for Two Years; Dasatinib Stop Trial
Sponsor: Shimousa Hematology Study Group
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module